144 related articles for article (PubMed ID: 28677030)
1. Regulation of Glioma Cells Migration by DYRK2.
Shen Y; Zhang L; Wang D; Bao Y; Liu C; Xu Z; Huang W; Cheng C
Neurochem Res; 2017 Nov; 42(11):3093-3102. PubMed ID: 28677030
[TBL] [Abstract][Full Text] [Related]
2. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
3. Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
Zhang X; Xu P; Ni W; Fan H; Xu J; Chen Y; Huang W; Lu S; Liang L; Liu J; Chen B; Shi W
Pathol Res Pract; 2016 Mar; 212(3):162-70. PubMed ID: 26804244
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TIP30 inhibits the growth and invasion of glioma cells.
Hu Y; Chen F; Liu F; Liu X; Huang N; Cai X; Sun Y; Li A; Luo R
Mol Med Rep; 2016 Jan; 13(1):605-12. PubMed ID: 26718891
[TBL] [Abstract][Full Text] [Related]
5. Gpx 4 is involved in the proliferation, migration and apoptosis of glioma cells.
Zhao H; Ji B; Chen J; Huang Q; Lu X
Pathol Res Pract; 2017 Jun; 213(6):626-633. PubMed ID: 28552540
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of PFTK1 Inhibits the Migration of Glioma Cells.
Fan S; Zhao C; Zhang L; Dai S; Ren J; Zhang X; Ban N; He X; Yang L; Bao Z; Chen W; Sun J; Gao Y; Tao T
J Mol Neurosci; 2015 Oct; 57(2):257-64. PubMed ID: 26234562
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.
Nomura S; Suzuki Y; Takahashi R; Terasaki M; Kimata R; Terasaki Y; Hamasaki T; Kimura G; Shimizu A; Kondo Y
BMC Urol; 2015 Jun; 15():53. PubMed ID: 26087959
[TBL] [Abstract][Full Text] [Related]
8. Enolase-phosphatase 1 as a novel potential malignant glioma indicator promotes cell proliferation and migration.
Su L; Yang K; Li S; Liu C; Han J; Zhang Y; Xu G
Oncol Rep; 2018 Oct; 40(4):2233-2241. PubMed ID: 30066900
[TBL] [Abstract][Full Text] [Related]
9. The role of FoxJ2 in the migration of human glioma cells.
Qiu X; Ji B; Yang L; Huang Q; Shi W; Ding Z; He X; Ban N; Fan S; Zhang J; Tian Y
Pathol Res Pract; 2015 May; 211(5):389-97. PubMed ID: 25661068
[TBL] [Abstract][Full Text] [Related]
10. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
11. Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Ito D; Yogosawa S; Mimoto R; Hirooka S; Horiuchi T; Eto K; Yanaga K; Yoshida K
Cancer Sci; 2017 Aug; 108(8):1565-1573. PubMed ID: 28502078
[TBL] [Abstract][Full Text] [Related]
12. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
14. High Expression of Pirh2 is Associated with Poor Prognosis in Glioma.
Bao Y; Wu X; Yuan D; Shi W; Shi J
Cell Mol Neurobiol; 2017 Nov; 37(8):1501-1509. PubMed ID: 28258514
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CAP1 and its significance in tumor cell proliferation, migration and invasion in glioma.
Fan YC; Cui CC; Zhu YS; Zhang L; Shi M; Yu JS; Bai J; Zheng JN
Oncol Rep; 2016 Sep; 36(3):1619-25. PubMed ID: 27432289
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
17. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
[TBL] [Abstract][Full Text] [Related]
18. Leptin induces migration and invasion of glioma cells through MMP-13 production.
Yeh WL; Lu DY; Lee MJ; Fu WM
Glia; 2009 Mar; 57(4):454-64. PubMed ID: 18814267
[TBL] [Abstract][Full Text] [Related]
19. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
[TBL] [Abstract][Full Text] [Related]
20. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
